NO985742L - IL-1/TNF-<alfa>-aktivert kinase (ITAK) og fremgangsmÕter for fremstilling og anvendelse av denne - Google Patents
IL-1/TNF-<alfa>-aktivert kinase (ITAK) og fremgangsmÕter for fremstilling og anvendelse av denneInfo
- Publication number
- NO985742L NO985742L NO985742A NO985742A NO985742L NO 985742 L NO985742 L NO 985742L NO 985742 A NO985742 A NO 985742A NO 985742 A NO985742 A NO 985742A NO 985742 L NO985742 L NO 985742L
- Authority
- NO
- Norway
- Prior art keywords
- itak
- tnf
- alpha
- processes
- activated kinase
- Prior art date
Links
- 108010002352 Interleukin-1 Proteins 0.000 title abstract 2
- 108091000080 Phosphotransferase Proteins 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 102000020233 phosphotransferase Human genes 0.000 title abstract 2
- 238000003556 assay Methods 0.000 abstract 2
- GOZMBJCYMQQACI-UHFFFAOYSA-N 6,7-dimethyl-3-[[methyl-[2-[methyl-[[1-[3-(trifluoromethyl)phenyl]indol-3-yl]methyl]amino]ethyl]amino]methyl]chromen-4-one;dihydrochloride Chemical compound Cl.Cl.C=1OC2=CC(C)=C(C)C=C2C(=O)C=1CN(C)CCN(C)CC(C1=CC=CC=C11)=CN1C1=CC=CC(C(F)(F)F)=C1 GOZMBJCYMQQACI-UHFFFAOYSA-N 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000005557 antagonist Substances 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Compounds Of Unknown Constitution (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US63341496A | 1996-06-10 | 1996-06-10 | |
| PCT/US1997/008516 WO1997047750A1 (en) | 1996-06-10 | 1997-06-09 | IL-1/TNF-α-ACTIVATED KINASE (ITAK), AND METHODS OF MAKING AND USING THE SAME |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO985742D0 NO985742D0 (no) | 1998-12-08 |
| NO985742L true NO985742L (no) | 1999-02-10 |
Family
ID=24539544
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO985742A NO985742L (no) | 1996-06-10 | 1998-12-08 | IL-1/TNF-<alfa>-aktivert kinase (ITAK) og fremgangsmÕter for fremstilling og anvendelse av denne |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0914451B1 (de) |
| JP (1) | JP2000512147A (de) |
| KR (1) | KR20000016286A (de) |
| AT (1) | ATE332974T1 (de) |
| AU (1) | AU718792B2 (de) |
| CA (1) | CA2257373A1 (de) |
| DE (1) | DE69736326T2 (de) |
| DK (1) | DK0914451T3 (de) |
| ES (1) | ES2270463T3 (de) |
| IL (1) | IL127363A (de) |
| NO (1) | NO985742L (de) |
| NZ (1) | NZ333214A (de) |
| PT (1) | PT914451E (de) |
| WO (1) | WO1997047750A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2481100A (en) * | 1998-12-18 | 2000-07-03 | Immunex Corporation | Methods for regulating vascularization using gef containing nek-like kinase (gnk) |
| WO2000073469A2 (en) * | 1999-05-28 | 2000-12-07 | Sugen, Inc. | Protein kinases |
| AU7986300A (en) * | 1999-09-27 | 2001-04-30 | Human Genome Sciences, Inc. | 43 human secreted proteins |
| US6911336B2 (en) | 2000-10-18 | 2005-06-28 | Immunex Corporation | GNK interacting amino acid decarboxylase and methods of use thereof |
| WO2003077875A2 (en) * | 2002-03-15 | 2003-09-25 | Incyte Corporation | Proteins associated with growth, differentiation, and death |
| US20060052582A1 (en) * | 2002-06-11 | 2006-03-09 | Joan Roig Amores | Identification of inhibitors of mitosis |
| WO2005019247A2 (en) | 2003-08-15 | 2005-03-03 | Board Of Regents, The University Of Texas System | Cyclic peptide and imaging compound compositions and uses for targeted imaging and therapy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5741667A (en) * | 1994-05-27 | 1998-04-21 | Genentech, Inc. | Tumor necrosis factor receptor-associated factors |
-
1997
- 1997-06-09 DK DK97928639T patent/DK0914451T3/da active
- 1997-06-09 NZ NZ333214A patent/NZ333214A/en unknown
- 1997-06-09 EP EP97928639A patent/EP0914451B1/de not_active Expired - Lifetime
- 1997-06-09 PT PT97928639T patent/PT914451E/pt unknown
- 1997-06-09 JP JP10501605A patent/JP2000512147A/ja not_active Ceased
- 1997-06-09 DE DE69736326T patent/DE69736326T2/de not_active Expired - Fee Related
- 1997-06-09 ES ES97928639T patent/ES2270463T3/es not_active Expired - Lifetime
- 1997-06-09 AU AU32842/97A patent/AU718792B2/en not_active Ceased
- 1997-06-09 CA CA002257373A patent/CA2257373A1/en not_active Abandoned
- 1997-06-09 AT AT97928639T patent/ATE332974T1/de not_active IP Right Cessation
- 1997-06-09 IL IL127363A patent/IL127363A/en not_active IP Right Cessation
- 1997-06-09 WO PCT/US1997/008516 patent/WO1997047750A1/en not_active Ceased
- 1997-06-09 KR KR1019980709859A patent/KR20000016286A/ko not_active Withdrawn
-
1998
- 1998-12-08 NO NO985742A patent/NO985742L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ATE332974T1 (de) | 2006-08-15 |
| JP2000512147A (ja) | 2000-09-19 |
| IL127363A (en) | 2007-05-15 |
| ES2270463T3 (es) | 2007-04-01 |
| DK0914451T3 (da) | 2006-11-13 |
| KR20000016286A (ko) | 2000-03-25 |
| EP0914451B1 (de) | 2006-07-12 |
| AU3284297A (en) | 1998-01-07 |
| WO1997047750A1 (en) | 1997-12-18 |
| AU718792B2 (en) | 2000-04-20 |
| CA2257373A1 (en) | 1997-12-18 |
| DE69736326T2 (de) | 2007-07-19 |
| EP0914451A1 (de) | 1999-05-12 |
| IL127363A0 (en) | 1999-10-28 |
| PT914451E (pt) | 2006-12-29 |
| NO985742D0 (no) | 1998-12-08 |
| NZ333214A (en) | 2000-02-28 |
| DE69736326D1 (de) | 2006-08-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0105337A2 (hu) | Az immunválaszban szerepet játszó új polipeptidek | |
| EP0653940A4 (de) | Glialmitogene faktoren, ihre herstellung und verwendung. | |
| IL196509A0 (en) | Antibodies directed aganist polypeptides capable of binding to ldcam, and pharmaceutical compositions comprising the same | |
| HUP0102257A2 (hu) | Módosított K-vitamin-dependens polipeptidek | |
| ATE384119T1 (de) | Isoprenoidproduktion | |
| NO882472D0 (no) | Fremgangsmaate for fremstilling av peptidborsyreinhibitorer for trypsinlignende proteaser. | |
| DE69942459D1 (de) | Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung | |
| EP0695171A1 (de) | Gonadotropin enthaltende gefriergetrocknete troepfen | |
| EP1009814A4 (de) | Kdr, ein menschlicher tyrosin kinase rezeptor | |
| DE68914664D1 (de) | Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden. | |
| DE69413039D1 (de) | Prostaglandin rezeptor fp und kodierende dns | |
| TR199900318T2 (xx) | IL-8 resept�r antagonistleri. | |
| ATE92523T1 (de) | Verfahren zur abtrennung und reinigung von sialyl-transferasen. | |
| HUP0003563A2 (hu) | Aminoterminálisa felől csonkolt MCP-2 mint kemokinantagonista | |
| ATE291585T1 (de) | Traf-inhibitoren | |
| ATE350472T1 (de) | Jmy, mit-aktivator für p300/cbp, dafür kodierendenucleinsäure und deren verwendungen | |
| NO985742L (no) | IL-1/TNF-<alfa>-aktivert kinase (ITAK) og fremgangsmÕter for fremstilling og anvendelse av denne | |
| NO903673D0 (no) | Fremgangsmaate for hurtigbestemmelse av innholdet av svellende leire i sementblandinger. | |
| DE69405230D1 (de) | Prostaglandinrezeptor ep1 kodierende dna | |
| FI972170A7 (fi) | Peptidejä, jotka kykenevät sitoutumaan GAP-proteiinin SH3-domeeniin, n äitä peptidejä koodittavia nukleotidisekvenssejä, niiden valmistus ja käyttö | |
| ATE48142T1 (de) | Blutprotein, verfahren zu seiner herstellung, antikoerper gegen dieses protein und dieses protein oder diese antikoerper enthaltende pharmazeutische zubereitungen. | |
| NO971378L (no) | Cytokin betegnet LERK-6 | |
| DK0939769T3 (da) | Vertebrat-Smoothened-proteiner | |
| SE9602822D0 (sv) | New receptor | |
| CA2067797A1 (en) | Production and use of human nm23 protein and antibodies therefor |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |